Quantum量子訊息有限公司
← 最新全球產業報告

ADME Toxicology Testing Market

研究執行與發布:Coherent Market Insights · 發布日期 2026-05-07 · 152 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

2026 年市場規模
USD 7.8 Bn
2033 年預估規模
USD 15.23 Bn
年複合成長率 CAGR
10.4%

以上數字由 Coherent Market Insights 於本報告中提出,量子訊息原樣引用。

出版商 Coherent Market Insights產業別 Healthcare & Life Sciences出版日期 2026-05-07頁數 152報告編號 CMI1013

授權報價

Single User Price$4,500 USD
Enterprise License$10,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
ADME Toxicology Testing Market, By Technology (Cell Culture Tech, High Throughput Tech, Molecular Imaging Tech, OMICS Technology), By Method (Cellular Assay, Biochemical Assay, In-Silica, Ex-vivo), By Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Toxicities), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

The ADME Toxicology Testing Market is estimated to be valued at USD 7.8 Bn in 2026 and is expected to reach USD 15.23 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 10.4% from 2026 to 2033. The market is undergoing a major transformation mainly driven by rising drug discovery activities, increasing regulatory emphasis on safety assessment, and growing demand for predictive toxicity screening. ADME toxicology testing evaluates how a drug is absorbed, distributed, metabolized, and excreted, while identifying potential toxicity risks before clinical development. The market includes a wide array of testing solutions such as in vitro ADME assays, in vivo toxicology studies, cell-based assays, high-throughput screening, computational toxicology, and pharmacokinetic profiling. The pharmaceutical and biotechnology firms are focusing on early-stage toxicity prediction to reduce late-stage drug failure and improve development efficiency. The advancements in organ-on-chip models, 3D cell cultures, AI-based predictive tools, and automated screening platforms are improving test accuracy, especially for complex drug candidates and biologics. In addition, the growing use of integrated ADME-tox workflows helps assess metabolic stability, drug-drug interaction risk, and safety margins, thereby improving both candidate selection and lowering overall R&D costs. Market Dynamics The ADME Toxicology Testing Market is witnessing substantial growth. This is owing to the increasing need for early-stage safety assessments in drug development, particularly as regulatory demands for preclinical testing intensify. The market’s growth is also largely attributed to the increasing focus on identifying drug toxicity profiles before clinical trials to reduce failure rates and minimize patient risks. In vitro ADME testing like absorption, distribution, metabolism, and excretion assays has become essential for early-stage screening. This is driven by the pharmaceutical firms encountering increasing pressure to optimize their development processes. The advanced testing technologies like high-throughput screening, microdosing studies, and in silico modeling are propelling market expansion, offering faster, more reliable results for toxicity prediction. Moreover, there is a rising emphasis on personalized medicine and biologics, which are pushing the need for tailored toxicology testing to ensure safety across diverse patient populations. The adoption of non-animal testing methods and computational toxicology models is becoming more widespread with regulatory agencies like the FDA and EMA requiring comprehensive ADME-toxicology data. The increasing investments in drug safety and the focus on reducing R&D costs are also contributing to market growth. The biotech and pharmaceutical companies are investing heavily in next-gen testing technologies. These advancements are expected to improve drug development efficiency, enhance patient safety, and ultimately reduce the cost of bringing new drugs to market. Key Features of the Study • This report provides in-depth analysis of the ADME Toxicology Testing Market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the ADME Toxicology Testing Market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Danaher, Charles River Laboratories, Promega Corporation, Agilent Technologies, Inc., Curia Global, Inc., Dassault Systèmes, Catalent, Inc., Labcorp, Eurofins Scientific, Miltenyi Biotec, IQVIA Inc. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The ADME Toxicology Testing Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the ADME Toxicology Testing Market Market Segmentation • By Technology (Revenue, USD Bn, 2021-2033) o Cell Culture Tech o High Throughput Tech o Molecular Imaging Tech o OMICS Technology • By Method (Revenue, USD Bn, 2021-2033) o Cellular Assay o Biochemical Assay o In-Silica o Ex-vivo • By Application (Revenue, USD Bn, 2021-2033) o Systemic Toxicity o Renal Toxicity o Hepatotoxicity o Neurotoxicity o Other Toxicities • By Region (Revenue, USD Bn, 2021-2033) o North America  U.S.  Canada o Latin America  Brazil  Mexico  Argentina  Rest of Latin America o Europe  Germany  U.K.  France  Italy  Spain  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC  Israel  Rest of Middle East o Africa  South Africa  Central Africa  North Africa • Key Players o Thermo Fisher Scientific, Inc. o Danaher o Charles River Laboratories o Promega Corporation o Agilent Technologies, Inc. o Curia Global, Inc. o Dassault Systemes o Catalent, Inc. o Labcorp o Eurofins Scientific o Miltenyi Biotec o IQVIA Inc.
目錄 Table of Contents
Table of Contents 1. Research Objective and Assumption o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snippet, By Technology  Market Snippet, By Method  Market Snippet, By Application  Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Key Developments o Technological Advancement o Regulatory Scenario 4. Global ADME Toxicology Testing Market, By Technology, 2021– 2033, (US$ Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022–2033  Segment Trends o Cell Culture Tech  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn) o High Throughput Tech  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn) o Molecular Imaging Tech  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn) o Molecular Imaging Tech  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn) o OMICS Technology  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn) 5. Global ADME Toxicology Testing Market, By Method, 2021 – 2033, (US$ Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022–2033  Segment Trends o Cellular Assay  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn) o Biochemical Assay  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn) o In-Silica  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn) o Ex-vivo  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn) 6. Global ADME Toxicology Testing Market, By Application, 2021– 2033, (US$ Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 – 2033  Segment Trends o Systemic Toxicity  Introduction  Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion) o Renal Toxicity  Introduction  Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion) o Hepatotoxicity  Introduction  Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion) o Neurotoxicity  Introduction  Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion) o Other Toxicities  Introduction  Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion) 7. Global ADME Toxicology Testing Market, By Region, 2021– 2033, (US$ Bn) o Introduction  Market Share Analysis, By Region, 2026 and 2033 (%)  Y-o-Y Growth Analysis, For Regions, 2022–2033 o North America  Market Size and Forecast, By Technology, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Method, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Application, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn) o U.S. o Canada o Latin America  Market Size and Forecast, By Technology, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Method, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Application, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Market Size and Forecast, By Technology, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Method, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Application, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn) o Germany o U.K. o France o Italy o Spain o Russia o Rest of Europe o Asia Pacific  Market Size and Forecast, By Technology, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Method, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Application, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of APAC o Middle East  Market Size and Forecast, By Technology, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Method, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Application, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn) o GCC o Israel o Rest of Middle East o Africa  Market Size and Forecast, By Technology, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Method, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Application, 2021 – 2033, (US$ Mn)  Market Size and Forecast, By Country, 2021 – 2033, (US$ Mn) o South Africa o Central Africa o North Africa 8. Competitive Landscape o Company Profiles  Thermo Fisher Scientific Inc. o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Danaher o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Charles River Laboratories o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Promega Corporation o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Agilent Technologies, Inc. o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Curia Global, Inc. o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Dassault Systemes o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Catalent, Inc. o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Labcorp o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Eurofins Scientific o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Miltenyi Biotec o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  IQVIA Inc. o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies 9. Section o References o Research Methodology o About us and Sales Contact Browse 24 market data tables and 20 figures on “ADME Toxicology Testing– Global forecast to 2033.

提及公司

Thermo Fisher Scientific, Inc.DanaherCharles River LaboratoriesPromega CorporationAgilent Technologies, Inc.Curia Global, Inc.Dassault SystemesCatalent, Inc.LabcorpEurofins ScientificMiltenyi BiotecIQVIA Inc.

同分類最新報告(醫療與生命科學)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們